PPPrasadini Perera

Prasadini Perera

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Prasadini Perera has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Diabetes Care Cascade in Sri Lanka: An Analysis of Losses, Disparities, and Opportunities for Improved Health System Outcomes

    by Ravindra P. Rannan-Eliya, Nilmini Wijemunige, H. M. M. Herath, Prasadini Perera, Vajira H.W. Dissanayake, Bilesha Perera, Shanti Dalpatadu, Sarath Samarage, Anuji Gamage

    Sri Lanka has one of the highest prevalence rates of diabetes, and improving diabetes control is a national priority. The care cascade framework, a tool for evaluating diabetes control and identifying system gaps, has not been assessed nationally in Sri Lanka. This study addresses this gap using data from a nationally representative longitudinal cohort. Using 2018-2019 data from the Sri Lanka Health and Ageing Study (SLHAS), we evaluated the diabetes care cascade, estimating levels of (i) prevalence, (ii) testing, (iii) diagnosis, (iv) awareness, (v) treatment, (vi) medication adherence, and (vii) control. Logistic regression assessed factors associated with step performance, and concentration indices quantified socioeconomic inequalities. Performance was benchmarked against other countries. In 4,827 participants the weighted diabetes prevalence was 23.2%. Of those with diabetes, 86.0% had been tested, 62.3% diagnosed, 58.6% aware, 44.7% treated, and 20.6% (hemoglobin A1c, HbA1c < 8.0%) and 12.4% (HbA1c < 7.0%) controlled. Older adults and those with hypertension achieved higher rates at all steps, while disparities by gender, education, location, and body mass index were minimal. Concentration indices confirmed pro-rich inequity from testing to treatment but revealed no significant inequity in control. Sri Lanka outperforms most low- and middle-income countries (LMICs) in testing, diagnosis, treatment, and disparities in coverage, reflecting underlying system strengths. But only one in five Sri Lankans with diabetes achieve control, with significant losses post-treatment. High diagnosis and treatment rates alone are insufficient; strategy must shift toward understanding the reasons for poor control. and improving treatment outcomes, a lesson with wider relevance.


  • Cohort Profile: The Sri Lanka Health and Ageing Study (SLHAS)

    by Ravindra P Rannan-Eliya, Vajira H Dissanayake, Prasadini Perera, Bilesha Perera, H M Meththananda Herath, Nilmini Wijemunige, Shanti Dalpatadu, Sarath Samarage, Anuji Gamage, Renuka Jayatissa, et al.

    Sri Lanka’s population is ageing with the elderly share of its population rapidly increasing. The country is also experiencing rapid epidemiological transition, with its mortality pattern now dominated by non-communicable diseases (NCDs), more similar to Europe than the rest of its region, 1 and life expectancy of 77 years close to that of the USA (78 years). 2 Access to health care services, at levels more comparable to high-income countries (HICs) than other developing countries, has contributed to these transitions, despite Sri Lanka still being a lower-middle-income country (LMIC) with inadequate social protection. 3 The experience of demographically advanced HICs provides pointers to future trends and potential responses, but Sri Lanka faces two added challenges. First, like some other Asian populations, population ageing is associated with a rising epidemic of diabetes and other metabolic disorders at younger ages and levels of body weight, the aetiology of which is not well understood. 4, 5 Second, this is occurring at lower levels of income and with inadequate government taxation. 1


  • Open Access

    Factors impacting sustained coverage in the context of donor transitions: experience from Sri Lanka

    by Prasadini N Perera, Sarasi N Amarasinghe, Sachini H Fonseka, Nihal Abeysinghe, Ravindra P Rannan-Eliya

    Although not reliant on donor funding for health, the external assistance that Sri Lanka receives contributes to the improvement of the health system and health outcomes. In this study, we evaluated transition experiences of the expanded programme on immunization (EPI) that received Gavi funding to expand the vaccine portfolio and the Anti-Malaria Campaign (AMC) that received funding from the Global Fund for AIDS, Tuberculosis and Malaria to scale-up interventions to target and achieve malaria elimination. We assessed if EPI and AMC programmes were able to sustain coverage of previously donor-funded interventions post-transition and explain the facilitators and barriers that contribute to this. We used a mixed methods approach using quantitative data to assess coverage indicators and the financing mix of the health programmes and qualitative analysis guided by a framework informed by the Walt and Gilson policy triangle that brought together document review and in-depth interviews to identify facilitators and barriers to transition success. The EPI programme showed sustained coverage of Gavi-funded vaccines post-transition and the funding gap was bridged by mobilizing domestic financing facilitated by the Gavi co-financing mechanism, full integration within existing service delivery structures, well-established and favourable pharmaceutical procurement processes for the public sector and stewardship and financial advocacy by technically competent managers. Although the absence of indigenous cases of malaria since 2012 suggests overall programme success, the AMC showed mixed transition success in relation to its different programme components. Donor-supported programme components requiring mobilization of operational expenses, facilitated by early financial planning, were successfully transitioned (e.g. entomological and parasitological surveillance) given COVID-19-related constraints. Other key programme components, such as research, training, education and awareness that are dependent on non-operational expenses are lagging behind. Additionally, concerns of AMC’s future financial sustainability within the current structure remain in the context of low malaria burden.


  • Electronic Copy Portfolio to an ePortfolio to Facilitate a Spirally Evolving Course on Health Humanities

    by Prasadini N. Perera, L. Chamila P. T. Liyanaarachchie, Rasnayaka M. Mudiyanse

  • Open Access

    Prevalence of diabetes and pre-diabetes in Sri Lanka: a new global hotspot–estimates from the Sri Lanka Health and Ageing Survey 2018/2019

    by Ravindra Prasan Rannan-Eliya, Nilmini Wijemunige, Prasadini Perera, Yasodhara Kapuge, Nishani Gunawardana, Chathurani Sigera, Renuka Jayatissa, H M M Herath, Anuji Gamage, Nethmi Weerawardena, et al.

    Introduction This study’s objective was to produce robust, comparable estimates of the prevalence of diabetes and pre-diabetes in the Sri Lankan adult population, where previous studies suggest the highest prevalence in South Asia. Research design and methods We used data on 6661 adults from the nationally representative 2018/2019 first wave of the Sri Lanka Health and Ageing Study (SLHAS). We classified glycemic status based on previous diabetes diagnosis, and either fasting plasma glucose (FPG), or FPG and 2-hour plasma glucose (2-h PG). We estimated crude and age-standardized prevalence of pre-diabetes and diabetes and by major individual characteristics weighting the data to account for study design and subject participation. Results Crude prevalence of diabetes in adults was 23.0% (95% CI 21.2% to 24.7%) using both 2-h PG and FPG, and age-standardized prevalence was 21.8% (95% CI 20.1% to 23.5%). Using only FPG, prevalence was 18.5% (95% CI 7.1% to 19.8%). Previously diagnosed prevalence was 14.3% (95% CI 13.1% to 15.5%) of all adults. The prevalence of pre-diabetes was 30.5% (95% CI 28.2% to 32.7%). Diabetes prevalence increased with age until ages ≥70 years and was more prevalent in female, urban, more affluent, and Muslim adults. Diabetes and pre-diabetes prevalence increased with body mass index (BMI) but was as high as 21% and 29%, respectively, in those of normal weight. Conclusions Study limitations included using only a single visit to assess diabetes, relying on self-reported fasting times, and unavailability of glycated hemoglobin for most participants. Our results indicate that Sri Lanka has a very high diabetes prevalence, significantly higher than previous estimates of 8%–15% and higher than current global estimates for any other Asian country. Our results have implications for other populations of South Asian origin, and the high prevalence of diabetes and dysglycemia at normal body weight indicates the need for further research to understand the underlying drivers.


  • Open Access

    Prevalence and Associations of Hypertension in Sri Lankan Adults: Estimates from the SLHAS 2018–19 Survey Using JNC7 and ACC/AHA 2017 Guidelines

    by Ravindra P. Rannan-Eliya, Nilmini Wijemunige, Prasadini Perera, Yasodhara Kapuge, Nishani Gunawardana, Chathurani Sigera, H. M. M. Herath, Bilesha Perera, Anuji Gamage, Nethmi Weerawardena, et al.

    Sri Lanka lacks robust estimates of hypertension (HTN) prevalence owing to few national studies, hindering optimization of control strategies. Evidence on how the revised 2017 American College of Cardiology/American Heart Association (ACC/AHA) HTN definition affects prevalence in low- and middle-income countries (LMICs) is also limited. To make robust estimates of HTN prevalence in the Sri Lankan adult population, and to assess impact of the ACC/AHA 2017 definitions. Data were sourced from the 2018–2019 first wave of the Sri Lanka Health and Ageing Study (SLHAS), a nationally representative longitudinal study of the noninstitutionalized adult population. After excluding those with missing data and aged <18 years, 6,342 participants (95.1%) were included in the analysis. HTN was defined using either the traditional threshold of systolic BP (SBP) ≥140 mmHg or a diastolic BP (DBP) ≥90 mmHg, or the ACC/AHA 2017 threshold of SBP ≥130 mmHg or DBP ≥80 mmHg, or if taking antihypertensive medication. Estimated prevalence of HTN in all Sri Lankan adults was 28.2% using the traditional definition, and it doubled to 51.3% when applying the ACC/AHA 2017 definition. Of those classified as hypertensive according to the older and ACC/AHA 2017 definitions, 53.4% and 31.2%, respectively, were previously diagnosed. Of the 23.2% of adults reclassified as hypertensive by the ACC/AHA 2017 definition, 16.6% had a history of CVD or diabetes. Increased prevalence was associated with urban residence, socioeconomic status, obesity, and Muslim ethnicity. Prevalence increased with age, but the increase was steeper in women from their 30s. Nearly one in three adult Sri Lankans are hypertensive, requiring antihypertensive treatment. Applying the ACC/AHA 2017 definitions almost doubles numbers, but many of those reclassified would require treatment under recent WHO guidelines. Study findings also suggest that design effects in HTN surveys may be higher than usually assumed.